口腔 (第二部分)
Michael A O Lewis1, Philip-John Lamey2
1School of Dentistry, Cardiff University School of Dentistry, Cardiff, United Kingdom. LewisMAO@cardif.ac.uk.
British dental journal
|December 15, 2023
概括
口腔是一种常见的牙科问题,通常是痛苦的,促使患者及时访问. 然而,早期的口腔状细胞癌可能是无痛的,需要活检检查持久性病变.
科学领域:
- 口服药是一种口服药.
- 牙科诊断 牙科诊断 牙科诊断
背景情况:
- 口腔是普通牙医经常遇到的情况.
- 大多数口腔是痛苦的,导致患者及时寻求牙科建议.
研究的目的:
- 突出无痛口腔病变所带来的诊断挑战.
- 强调活检对持续性口腔的重要性.
主要方法:
- 对口腔粘膜状况的临床表现的审查.
- 强调口腔的诊断标准.
主要成果:
- 口腔状细胞癌可以呈现为无痛的,特别是在早期.
- 持续的口腔,无论疼痛,需要确定的诊断.
结论:
- 一般牙医必须警潜在的恶性无痛口腔病变.
- 粘膜活检是诊断持续性口腔的黄金标准,以排除口腔癌.
相关概念视频
Peptic Ulcer Disease I: Introduction
176
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
176
Peptic Ulcer Disease II: Pathophysiology
451
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
451
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
497
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
497
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
130
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
130
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
434
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
434
Peptic Ulcer Disease IV: Management
95
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
95


